Ainos, Inc. (NASDAQ:AIMD – Get Free Report) saw a significant drop in short interest during the month of September. As of September 15th, there was short interest totalling 122,800 shares, a drop of 27.9% from the August 31st total of 170,400 shares. Based on an average daily trading volume, of 521,300 shares, the days-to-cover ratio is presently 0.2 days. Approximately 8.4% of the shares of the company are sold short.
Ainos Trading Down 5.4 %
AIMD opened at $0.50 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.48 and a quick ratio of 1.45. The company’s 50 day moving average is $0.60 and its 200 day moving average is $0.86. Ainos has a 12-month low of $0.45 and a 12-month high of $4.29.
Ainos (NASDAQ:AIMD – Get Free Report) last posted its quarterly earnings data on Monday, August 5th. The company reported ($0.49) earnings per share (EPS) for the quarter. Ainos had a negative return on equity of 64.54% and a negative net margin of 15,348.14%.
Ainos Company Profile
Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.
Read More
- Five stocks we like better than Ainos
- Differences Between Momentum Investing and Long Term Investing
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
- How to Effectively Use the MarketBeat Ratings Screener
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Profitably Trade Stocks at 52-Week Highs
- MarketBeat Week in Review – 9/23 – 9/27
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.